{ "cik": 1438533, "cik_padded": "0001438533", "entityName": "Travere Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001438533-26-000014", "filed": "2026-02-19", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 93035000.0, "eps_diluted": -0.29, "net_income": -25546000.0, "operating_cash_flow": 37784000.0, "operating_income": -62824000.0, "revenue": 490728000.0, "stockholders_equity": 114828000.0, "total_assets": 605191000.0, "total_liabilities": 490363000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 4.27041313965235, "net_margin": -0.052057351526711336, "operating_margin": -0.12802204072317047, "revenue_growth_yoy": 1.1045480862013508, "roa_avg2y": -0.042600949207715066, "roa_period_end": -0.0422114671236023, "roe_avg2y": -0.2937925879071907, "roe_period_end": -0.22247187097223672 } }, { "accn": "0001438533-26-000014", "filed": "2026-02-19", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 58535000.0, "eps_diluted": -4.08, "net_income": -321545000.0, "operating_cash_flow": -237475000.0, "operating_income": -323827000.0, "revenue": 233175000.0, "stockholders_equity": 59077000.0, "total_assets": 594125000.0, "total_liabilities": 535048000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 9.056790290637643, "net_margin": -1.378985740323791, "operating_margin": -1.3887723812587112, "revenue_growth_yoy": 0.6054682658808301, "roa_avg2y": -0.4649836085487167, "roa_period_end": -0.5412076583210604, "roe_avg2y": -2.474498532054316 } }, { "accn": "0001438533-26-000014", "filed": "2026-02-19", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 58176000.0, "eps_diluted": -1.5, "net_income": -111399000.0, "operating_cash_flow": -280021000.0, "operating_income": -388138000.0, "revenue": 145238000.0, "stockholders_equity": 200810000.0, "total_assets": 788913000.0, "total_liabilities": 588103000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.9286539514964396, "net_margin": -0.7670100111541057, "revenue_growth_yoy": 0.32685912662159694, "roa_avg2y": -0.15244495716039297, "roa_period_end": -0.1412056842769735, "roe_avg2y": -0.9143769417346231, "roe_period_end": -0.5547482695084907 } }, { "accn": "0001438533-26-000014", "filed": "2026-02-19", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 61688000.0, "eps_diluted": -4.37, "net_income": -278482000.0, "operating_cash_flow": -186291000.0, "operating_income": -319813000.0, "revenue": 109460000.0, "stockholders_equity": 42851000.0, "total_assets": 672585000.0, "total_liabilities": 629734000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 14.695899745630207, "revenue_growth_yoy": -0.1697260232409964, "roa_avg2y": -0.3843203714003, "roa_period_end": -0.41404729513741756, "roe_avg2y": -1.6145615616747304 } }, { "accn": "0001438533-25-000010", "filed": "2025-02-21", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 165753000.0, "eps_diluted": -3.01, "net_income": -180091000.0, "operating_cash_flow": -14792000.0, "operating_income": -199425000.0, "revenue": 131836000.0, "stockholders_equity": 302112000.0, "total_assets": 776633000.0, "total_liabilities": 474521000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.570679085901917, "net_margin": -1.366022937589126, "revenue_growth_yoy": -0.3352393342106988, "roa_avg2y": -0.2602335716639019, "roa_period_end": -0.23188687578302752, "roe_avg2y": -0.701664637412945, "roe_period_end": -0.5961067418705646 } }, { "accn": "0001438533-24-000005", "filed": "2024-02-20", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 84772000.0, "eps_diluted": -3.56, "net_income": -169431000.0, "operating_cash_flow": -42743000.0, "operating_income": -176163000.0, "revenue": 198321000.0, "stockholders_equity": 211213000.0, "total_assets": 607439000.0, "total_liabilities": 396226000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.875954605066923, "net_margin": -0.8543270758013523, "operating_margin": -0.8882720438077663, "revenue_growth_yoy": 0.13107826027444136, "roa_avg2y": -0.27953398628488274, "roa_period_end": -0.27892677289406836, "roe_avg2y": -0.783660839621747, "roe_period_end": -0.8021807369811518 } }, { "accn": "0001438533-23-000008", "filed": "2023-02-23", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 62436000.0, "eps_diluted": -3.46, "net_income": -146427000.0, "operating_cash_flow": -58214000.0, "operating_income": -137361000.0, "revenue": 175338000.0, "stockholders_equity": 221196000.0, "total_assets": 604800000.0, "total_liabilities": 383604000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.7342266587099224, "net_margin": -0.8351127536529446, "operating_margin": -0.783406905519625, "revenue_growth_yoy": 0.06753284707085713, "roa_avg2y": -0.22287893086547536, "roa_period_end": -0.24210813492063493, "roe_avg2y": -0.5428761569675725, "roe_period_end": -0.6619785167905389 } }, { "accn": "0001438533-22-000008", "filed": "2022-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 102873000.0, "eps_diluted": -2.54, "net_income": -102678000.0, "operating_cash_flow": -24958000.0, "operating_income": -80040000.0, "revenue": 164246000.0, "stockholders_equity": 318253000.0, "total_assets": 709160000.0, "total_liabilities": 390907000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.2282900711069495, "net_margin": -0.6251476443870779, "operating_margin": -0.4873178037821317, "revenue_growth_yoy": 0.06008248513912106, "roa_avg2y": -0.16702317841474543, "roa_period_end": -0.14478820012409047, "roe_avg2y": -0.33588545389417834, "roe_period_end": -0.3226301087499568 } }, { "accn": "0001438533-21-000008", "filed": "2021-03-01", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 99394000.0, "eps_diluted": -1.54, "net_income": -59731000.0, "operating_cash_flow": 7403000.0, "operating_income": -53791000.0, "revenue": 154937000.0, "stockholders_equity": 293134000.0, "total_assets": 520346000.0, "total_liabilities": 227212000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7751130882122169, "net_margin": -0.38551798472927706, "operating_margin": -0.34717982147582566, "revenue_growth_yoy": 0.15978621314310096, "roa_avg2y": -0.11424904459329704, "roa_period_end": -0.1147909275751135, "roe_avg2y": -0.19880479479980895, "roe_period_end": -0.2037668779466046 } }, { "accn": "0001438533-20-000004", "filed": "2020-02-24", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 41002000.0, "eps_diluted": -1.29, "net_income": -47903000.0, "operating_cash_flow": -3441000.0, "operating_income": -58214000.0, "revenue": 133591000.0, "stockholders_equity": 307767000.0, "total_assets": 525282000.0, "total_liabilities": 217515000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.706752185906871, "net_margin": -0.358579545029231, "operating_margin": -0.43576288821851766, "roa_period_end": -0.09119482487501951, "roe_period_end": -0.15564696669883385 } } ], "latest_filing": { "accn": "0001438533-26-000014", "filed": "2026-02-19", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001438533.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001438533.json" }, "ticker": "TVTX" }